Exponent (EXPO) Financials

$74.86 -0.33 (-0.44%)

Closing price 05/7/2025 03:59 PM Eastern

Extended Trading

$74.86 0.00 (-0.01%)

As of 05/7/2025 04:20 PM Eastern

Annual Income Statements for Exponent

This table shows Exponent's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	1/1/2016	12/30/2016	12/29/2017	12/28/2018	1/3/2020	1/1/2021	12/31/2021	12/30/2022	12/29/2023	1/3/2025
Net Income / (Loss) Attributable to Common Shareholders	44	47	41	72	82	83	101	102	100	109
Consolidated Net Income / (Loss)	44	47	41	72	82	83	101	102	100	109
Net Income / (Loss) Continuing Operations	44	47	41	72	82	83	101	102	100	109
Total Pre-Tax Income	71	69	83	93	104	97	126	132	136	147
Total Operating Income	69	62	72	91	85	83	109	141	111	120
Total Gross Profit	128	122	138	164	165	150	188	249	217	229
Total Revenue	313	315	348	380	417	400	466	513	537	559
Operating Revenue	313	315	348	380	417	400	466	513	537	559
Total Cost of Revenue	185	193	210	215	252	250	278	264	320	330
Operating Cost of Revenue	185	193	210	215	252	250	278	264	320	330
Total Operating Expenses	59	60	65	73	80	67	79	108	106	109
Selling, General & Admin Expense	42	44	47	48	54	45	48	59	66	69
Other Operating Expenses / (Income)	17	16	18	25	26	21	31	49	40	40
Total Other Income / (Expense), net	2.20	7.21	10	1.86	19	14	17	-8.61	25	28
Interest & Investment Income	0.21	0.68	1.29	2.75	3.91	1.71	0.07	2.10	7.15	10
Other Income / (Expense), net	1.99	6.53	9.16	-0.89	15	12	17	-11	17	18
Income Tax Expense	28	22	41	21	22	14	25	30	36	38
Basic Earnings per Share	$1.64	$0.90	$0.78	$1.37	$1.56	$1.58	$1.92	$1.98	$1.96	$2.13
Weighted Average Basic Shares Outstanding	26.61M	52.98M	52.72M	52.91M	52.69M	52.39M	52.61M	51.73M	51.15M	51.13M
Diluted Earnings per Share	$1.60	$0.87	$0.77	$1.33	$1.53	$1.55	$1.90	$1.96	$1.94	$2.11
Weighted Average Diluted Shares Outstanding	27.30M	54.33M	53.97M	54.17M	53.88M	53.32M	53.33M	52.28M	51.64M	51.57M
Weighted Average Basic & Diluted Shares Outstanding	26.60M	26.50M	53M	52.70M	51.82M	51.80M	52.12M	50.64M	50.56M	50.82M
Cash Dividends to Common per Share	$0.60	$0.36	$0.42	$0.52	$0.64	$0.76	$0.80	$0.96	$1.04	$1.12

This table shows Exponent's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/30/2022	3/31/2023	6/30/2023	9/29/2023	12/29/2023	3/29/2024	6/28/2024	9/27/2024	1/3/2025
Net Income / (Loss) Attributable to Common Shareholders	24	23	29	26	25	21	30	29	26	24
Consolidated Net Income / (Loss)	24	23	29	26	25	21	30	29	26	24
Net Income / (Loss) Continuing Operations	24	23	29	26	25	21	30	29	26	24
Total Pre-Tax Income	33	31	36	36	34	30	40	40	36	31
Total Operating Income	37	22	29	30	34	18	31	36	26	27
Total Gross Profit	64	53	56	57	59	44	55	61	54	59
Total Revenue	127	127	140	140	133	123	145	141	136	137
Operating Revenue	127	127	140	140	133	123	145	141	136	137
Total Cost of Revenue	63	74	84	83	74	79	90	79	82	78
Operating Cost of Revenue	63	74	84	83	74	79	90	79	82	78
Total Operating Expenses	28	31	27	28	25	26	24	25	28	31
Selling, General & Admin Expense	16	16	15	17	17	17	16	17	17	18
Other Operating Expenses / (Income)	12	15	12	11	8.38	9.03	7.73	8.10	11	13
Total Other Income / (Expense), net	-3.34	8.48	6.42	6.38	0.08	12	9.71	3.94	10	4.08
Interest & Investment Income	0.64	1.26	1.77	1.59	1.86	1.93	2.63	2.23	2.56	2.59
Other Income / (Expense), net	-3.98	7.22	4.65	4.79	-1.77	9.77	7.08	1.71	7.53	1.49
Income Tax Expense	9.03	8.00	6.41	11	9.48	9.16	10	10	9.89	7.74
Basic Earnings per Share	$0.47	$0.45	$0.57	$0.50	$0.48	$0.41	$0.59	$0.57	$0.51	$0.46
Weighted Average Basic Shares Outstanding	51.49M	51.73M	51.13M	51.26M	51.20M	51.15M	51.01M	51.11M	51.18M	51.13M
Diluted Earnings per Share	$0.47	$0.44	$0.56	$0.50	$0.48	$0.40	$0.59	$0.57	$0.50	$0.45
Weighted Average Diluted Shares Outstanding	52.01M	52.28M	51.68M	51.69M	51.65M	51.64M	51.42M	51.52M	51.62M	51.57M
Weighted Average Basic & Diluted Shares Outstanding	50.64M	50.64M	50.84M	50.85M	50.62M	50.56M	50.67M	50.73M	50.76M	50.82M
Cash Dividends to Common per Share	$0.24	$0.24	$0.26	$0.26	$0.26	$0.26	$0.28	$0.28	$0.28	$0.28

This table details how cash moves in and out of Exponent's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	1/1/2016	12/30/2016	12/29/2017	12/28/2018	1/3/2020	1/1/2021	12/31/2021	12/30/2022	12/29/2023	1/3/2025
Net Change in Cash & Equivalents	-3.74	-11	9.83	2.27	49	21	100	-136	26	72
Net Cash From Operating Activities	60	67	68	91	108	103	125	94	127	145
Net Cash From Continuing Operating Activities	60	67	68	91	108	103	125	94	127	145
Net Income / (Loss) Continuing Operations	44	47	41	72	82	83	101	102	100	109
Consolidated Net Income / (Loss)	44	47	41	72	82	83	101	102	100	109
Depreciation Expense	5.48	6.13	6.29	6.29	6.81	6.87	6.49	7.08	8.92	9.69
Amortization Expense	0.60	0.00	0.00	-0.11	-0.52	-0.16	-0.01	0.00	0.00	0.00
Non-Cash Adjustments To Reconcile Net Income	7.49	16	18	19	20	19	21	23	24	28
Changes in Operating Assets and Liabilities, net	3.32	-2.45	1.95	-6.26	-0.38	-5.08	-4.33	-39	-5.49	-1.84
Net Cash From Investing Activities	-27	-27	-18	-26	4.27	5.02	38	-12	-16	-6.94
Net Cash From Continuing Investing Activities	-27	-27	-18	-26	4.27	5.02	38	-12	-16	-6.94
Purchase of Property, Plant & Equipment	-5.38	-14	-4.73	-16	-23	-4.99	-6.83	-12	-16	-6.94
Purchase of Investments	-44	-51	-29	-53	-39	-40	-35	0.00	0.00	0.00
Sale and/or Maturity of Investments	22	38	16	43	66	50	80	0.00	0.00	0.00
Net Cash From Financing Activities	-37	-49	-41	-63	-63	-88	-63	-216	-86	-65
Net Cash From Continuing Financing Activities	-37	-49	-41	-63	-63	-88	-63	-216	-86	-65
Repurchase of Common Equity	-23	-24	-12	-28	-22	-40	-7.00	-156	-24	-5.71
Payment of Dividends	-16	-19	-22	-27	-34	-40	-43	-49	-54	-58
Issuance of Common Equity	3.01	1.76	2.03	1.47	3.23	6.73	3.11	2.02	2.18	5.74
Other Financing Activities, net	-0.97	-7.69	-9.52	-8.84	-11	-15	-16	-13	-9.94	-6.92
Effect of Exchange Rate Changes	-0.28	-1.12	0.97	-0.60	0.46	1.11	0.17	-2.02	0.71	-0.74

This table details how cash moves in and out of Exponent's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/30/2022	3/31/2023	6/30/2023	9/29/2023	12/29/2023	3/29/2024	6/28/2024	9/27/2024	1/3/2025
Net Change in Cash & Equivalents	-17	13	-36	23	-11	50	-18	35	16	39
Net Cash From Operating Activities	29	41	-6.70	41	22	71	10	48	30	56
Net Cash From Continuing Operating Activities	29	41	-6.70	41	22	71	10	48	30	56
Net Income / (Loss) Continuing Operations	24	23	29	26	25	21	30	29	26	24
Consolidated Net Income / (Loss)	24	23	29	26	25	21	30	29	26	24
Depreciation Expense	1.72	1.86	1.99	2.19	2.36	2.38	2.32	2.49	2.39	2.49
Non-Cash Adjustments To Reconcile Net Income	5.25	5.26	7.96	5.62	5.52	4.49	8.62	6.66	6.25	6.17
Changes in Operating Assets and Liabilities, net	-1.99	11	-46	6.99	-10	44	-31	9.97	-4.97	24
Net Cash From Investing Activities	-3.19	-2.94	-5.67	-5.45	-3.31	-1.93	-1.48	-1.15	-1.71	-2.60
Net Cash From Continuing Investing Activities	-3.19	-2.94	-5.67	-5.45	-3.31	-1.93	-1.48	-1.15	-1.71	-2.60
Purchase of Property, Plant & Equipment	-3.19	-2.94	-5.67	-5.45	-3.31	-1.93	-1.48	-1.15	-1.71	-2.60
Net Cash From Financing Activities	-42	-25	-24	-13	-30	-20	-27	-13	-13	-12
Net Cash From Continuing Financing Activities	-42	-25	-24	-13	-30	-20	-27	-13	-13	-12
Repurchase of Common Equity	-30	-14	0.00	-	-17	-7.24	-5.47	-0.24	0.00	-0.00
Payment of Dividends	-12	-12	-15	-13	-13	-13	-16	-14	-14	-14
Issuance of Common Equity	0.56	0.39	0.68	0.56	0.57	0.37	0.62	1.84	1.29	2.00
Other Financing Activities, net	-	-	-9.92	-	-	-0.02	-6.80	-	-0.03	-0.09
Effect of Exchange Rate Changes	-1.38	0.80	0.30	0.08	-0.39	0.71	-0.21	0.01	1.41	-1.94

This table presents Exponent's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	1/1/2016	12/30/2016	12/29/2017	12/28/2018	1/3/2020	1/1/2021	12/31/2021	12/30/2022	12/29/2023	1/3/2025
Total Assets	388	404	440	469	563	580	684	587	647	777
Total Current Assets	273	274	316	327	364	367	453	349	380	447
Cash & Equivalents	126	115	125	127	176	198	298	161	187	259
Accounts Receivable	89	87	110	106	120	112	140	170	167	161
Prepaid Expenses	13	13	9.01	12	12	13	15	18	25	27
Plant, Property, & Equipment, net	28	37	35	46	62	60	60	66	75	73
Total Noncurrent Assets	86	93	89	96	138	153	171	172	192	257
Goodwill	8.61	8.61	8.61	8.61	8.61	8.61	8.61	8.61	8.61	8.61
Noncurrent Deferred & Refundable Income Taxes	39	42	30	34	37	41	47	54	54	57
Other Noncurrent Operating Assets	1.65	1.06	1.35	54	92	104	116	109	129	192
Total Liabilities & Shareholders' Equity	388	404	440	469	563	580	684	587	647	777
Total Liabilities	125	130	151	155	213	219	267	266	291	356
Total Current Liabilities	80	80	93	98	124	117	153	159	162	163
Accounts Payable	11	10	15	12	19	16	25	29	22	22
Current Deferred Revenue	7.80	7.62	8.30	9.17	13	12	20	19	22	16
Current Employee Benefit Liabilities	62	63	70	77	87	83	104	106	112	119
Other Current Liabilities	-	-	-	0.00	5.94	5.99	5.16	5.26	6.30	5.39
Total Noncurrent Liabilities	44	50	57	57	89	101	114	107	129	193
Noncurrent Employee Benefit Liabilities	40	47	53	53	68	84	101	91	103	113
Other Noncurrent Operating Liabilities	1.91	2.01	3.33	2.55	21	2.99	13	16	25	80
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	263	273	289	314	350	361	417	321	356	421
Total Preferred & Common Equity	263	273	289	314	350	361	417	321	356	421
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	263	273	289	311	348	360	417	321	356	421
Common Stock	180	195	210	227	245	265	281	301	322	346
Retained Earnings	269	291	304	342	385	422	478	529	574	624
Treasury Stock	-184	-209	-223	-253	-278	-324	-341	-506	-537	-545
Accumulated Other Comprehensive Income / (Loss)	-1.81	-3.13	-2.03	-5.71	-3.52	-3.86	-1.98	-3.59	-2.98	-3.79

This table presents Exponent's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/29/2023	3/29/2024	6/28/2024	9/27/2024
Total Assets	559	566	604	602	629	709	744
Total Current Assets	333	318	345	343	352	391	413
Cash & Equivalents	148	126	148	137	169	203	220
Accounts Receivable	166	173	176	182	163	166	169
Prepaid Expenses	18	20	21	24	21	22	24
Plant, Property, & Equipment, net	64	69	77	76	75	73	73
Total Noncurrent Assets	162	179	183	183	203	245	259
Goodwill	8.61	8.61	8.61	8.61	8.61	8.61	8.61
Noncurrent Deferred & Refundable Income Taxes	51	52	52	54	52	52	54
Other Noncurrent Operating Assets	103	118	122	120	142	185	196
Total Liabilities & Shareholders' Equity	559	566	604	602	629	709	744
Total Liabilities	239	225	247	249	255	316	334
Total Current Liabilities	138	109	125	130	114	132	138
Accounts Payable	32	26	20	20	24	22	23
Current Deferred Revenue	16	15	11	10	16	14	13
Current Employee Benefit Liabilities	85	63	88	94	68	91	97
Other Current Liabilities	5.36	4.90	5.75	5.70	5.81	4.90	4.94
Total Noncurrent Liabilities	101	115	123	119	141	184	196
Noncurrent Employee Benefit Liabilities	85	101	96	93	116	109	116
Other Noncurrent Operating Liabilities	16	14	26	26	25	76	81
Total Equity & Noncontrolling Interests	320	342	357	354	374	393	410
Total Preferred & Common Equity	320	342	357	354	374	393	410
Total Common Equity	320	342	357	354	374	393	410
Common Stock	299	315	317	320	335	339	342
Retained Earnings	519	543	555	567	589	603	615
Treasury Stock	-492	-513	-512	-529	-546	-546	-545
Accumulated Other Comprehensive Income / (Loss)	-5.14	-3.13	-3.26	-3.78	-3.19	-3.17	-1.61

This table displays calculated financial ratios and metrics derived from Exponent's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	1/1/2016	12/30/2016	12/29/2017	12/28/2018	1/3/2020	1/1/2021	12/31/2021	12/30/2022	12/29/2023	1/3/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	2.67%	0.72%	10.39%	9.12%	9.93%	-4.15%	16.60%	10.09%	4.57%	4.05%
EBITDA Growth	3.91%	-3.15%	17.34%	10.56%	10.15%	-4.34%	29.73%	3.76%	0.32%	6.83%
EBIT Growth	4.59%	-3.51%	18.67%	11.51%	10.72%	-5.03%	32.07%	3.47%	-1.07%	6.70%
NOPAT Growth	11.02%	0.65%	-15.18%	96.32%	-4.88%	5.25%	23.56%	24.42%	-24.59%	7.59%
Net Income Growth	7.12%	8.90%	-13.01%	74.93%	14.13%	0.11%	22.59%	1.11%	-1.95%	8.63%
EPS Growth	8.84%	8.90%	-13.01%	72.73%	15.04%	1.31%	22.58%	3.16%	-1.02%	8.76%
Operating Cash Flow Growth	25.36%	10.67%	1.33%	34.42%	18.50%	-4.39%	20.57%	-24.69%	35.76%	13.49%
Free Cash Flow Firm Growth	50.95%	-16.64%	26.06%	35.22%	-7.02%	4.01%	80.58%	-31.97%	5.04%	31.21%
Invested Capital Growth	1.48%	9.22%	-6.96%	13.66%	12.62%	12.36%	-10.45%	33.44%	6.05%	-4.01%
Revenue Q/Q Growth	0.02%	1.07%	3.35%	1.03%	4.50%	-1.69%	2.25%	2.77%	-0.82%	2.55%
EBITDA Q/Q Growth	-0.02%	1.06%	4.30%	0.75%	5.00%	0.68%	1.45%	0.68%	-0.41%	0.47%
EBIT Q/Q Growth	0.16%	1.02%	4.78%	0.80%	4.99%	0.88%	1.63%	0.47%	-0.85%	0.43%
NOPAT Q/Q Growth	1.38%	1.08%	-26.07%	50.57%	-6.89%	-0.92%	2.46%	-0.25%	-4.38%	9.77%
Net Income Q/Q Growth	1.41%	1.15%	-25.44%	37.59%	3.89%	3.41%	-1.42%	2.14%	-1.56%	2.50%
EPS Q/Q Growth	-1.23%	1.15%	-25.44%	34.34%	2.00%	1.31%	-1.55%	3.16%	-2.02%	2.43%
Operating Cash Flow Q/Q Growth	7.09%	5.57%	19.69%	3.98%	11.80%	-12.61%	11.98%	-12.68%	31.82%	-9.55%
Free Cash Flow Firm Q/Q Growth	16.60%	9.46%	40.04%	9.24%	55.61%	-35.22%	34.97%	-30.10%	77.91%	-10.64%
Invested Capital Q/Q Growth	-13.54%	-14.42%	-31.08%	-17.87%	-28.48%	-11.50%	-25.81%	-7.04%	-21.98%	-14.90%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	41.02%	38.62%	39.54%	43.34%	39.55%	37.47%	40.37%	48.52%	40.40%	40.91%
EBITDA Margin	24.61%	23.67%	25.16%	25.49%	25.54%	25.49%	28.36%	26.73%	25.65%	26.33%
Operating Margin	22.04%	19.65%	20.72%	24.10%	20.40%	20.82%	23.36%	27.44%	20.74%	21.41%
EBIT Margin	22.67%	21.72%	23.35%	23.86%	24.04%	23.81%	26.97%	25.35%	23.99%	24.60%
Profit (Net Income) Margin	13.94%	15.07%	11.88%	19.04%	19.77%	20.64%	21.70%	19.94%	18.69%	19.52%
Tax Burden Percent	61.29%	68.69%	50.06%	77.43%	79.14%	85.16%	80.42%	77.39%	73.84%	73.96%
Interest Burden Percent	100.29%	101.00%	101.59%	103.04%	103.90%	101.79%	100.05%	101.61%	105.55%	107.28%
Effective Tax Rate	38.71%	31.31%	49.94%	22.57%	20.86%	14.84%	19.58%	22.61%	26.16%	26.04%
Return on Invested Capital (ROIC)	46.66%	44.57%	37.51%	71.51%	60.14%	56.27%	69.34%	78.22%	50.08%	53.42%
ROIC Less NNEP Spread (ROIC-NNEP)	45.83%	41.70%	34.68%	70.80%	53.28%	51.20%	64.16%	81.12%	39.67%	44.19%
Return on Net Nonoperating Assets (RNNOA)	-29.47%	-26.86%	-22.82%	-47.55%	-35.31%	-33.08%	-43.34%	-50.48%	-20.43%	-25.36%
Return on Equity (ROE)	17.20%	17.71%	14.69%	23.97%	24.83%	23.20%	26.00%	27.74%	29.65%	28.05%
Cash Return on Invested Capital (CROIC)	45.20%	35.75%	44.72%	58.72%	48.27%	44.63%	80.37%	49.57%	44.21%	57.50%
Operating Return on Assets (OROA)	18.84%	17.30%	19.26%	19.94%	19.43%	16.66%	19.90%	20.49%	20.88%	19.29%
Return on Assets (ROA)	11.58%	12.00%	9.80%	15.91%	15.98%	14.44%	16.02%	16.11%	16.27%	15.31%
Return on Common Equity (ROCE)	17.20%	17.71%	14.69%	23.85%	24.66%	23.08%	25.93%	27.74%	29.65%	28.05%
Return on Equity Simple (ROE_SIMPLE)	16.59%	17.37%	14.29%	23.02%	23.54%	22.84%	24.27%	31.90%	28.18%	25.89%
Net Operating Profit after Tax (NOPAT)	42	43	36	71	67	71	88	109	82	88
NOPAT Margin	13.51%	13.50%	10.37%	18.66%	16.15%	17.73%	18.79%	21.23%	15.31%	15.83%
Net Nonoperating Expense Percent (NNEP)	0.83%	2.87%	2.83%	0.71%	6.86%	5.07%	5.17%	-2.90%	10.41%	9.22%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	33.98%	23.08%	21.00%
Cost of Revenue to Revenue	58.98%	61.38%	60.46%	56.66%	60.45%	62.53%	59.63%	51.48%	59.60%	59.09%
SG&A Expenses to Revenue	13.51%	13.93%	13.61%	12.68%	12.96%	11.28%	10.27%	11.44%	12.29%	12.34%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	18.99%	18.97%	18.82%	19.24%	19.15%	16.66%	17.01%	21.08%	19.67%	19.51%
Earnings before Interest and Taxes (EBIT)	71	68	81	91	100	95	126	130	129	137
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	77	75	88	97	107	102	132	137	138	147
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.46	5.22	5.95	7.90	10.02	12.48	14.19	15.28	12.37	10.72
Price to Tangible Book Value (P/TBV)	4.61	5.39	6.13	8.12	10.27	12.78	14.48	15.71	12.67	10.94
Price to Revenue (P/Rev)	3.75	4.53	4.94	6.47	8.37	11.22	12.69	9.55	8.20	8.08
Price to Earnings (P/E)	26.91	30.05	41.62	33.99	42.33	54.34	58.46	47.91	43.89	41.41
Dividend Yield	1.32%	1.29%	1.26%	0.96%	0.95%	0.87%	0.70%	0.99%	1.20%	1.26%
Earnings Yield	3.72%	3.33%	2.40%	2.94%	2.36%	1.84%	1.71%	2.09%	2.28%	2.42%
Enterprise Value to Invested Capital (EV/IC)	10.98	12.58	16.43	21.33	27.46	31.94	47.07	29.76	24.96	26.24
Enterprise Value to Revenue (EV/Rev)	3.20	3.98	4.38	5.92	7.81	10.65	12.05	9.24	7.86	7.62
Enterprise Value to EBITDA (EV/EBITDA)	13.01	16.80	17.40	23.23	30.58	41.77	42.49	34.55	30.63	28.93
Enterprise Value to EBIT (EV/EBIT)	14.12	18.31	18.75	24.81	32.50	44.71	44.67	36.43	32.75	30.97
Enterprise Value to NOPAT (EV/NOPAT)	23.70	29.46	42.21	31.74	48.38	60.06	64.14	43.50	51.30	48.11
Enterprise Value to Operating Cash Flow (EV/OCF)	16.56	18.72	22.44	24.64	30.16	41.21	45.11	50.54	33.11	29.44
Enterprise Value to Free Cash Flow (EV/FCFF)	24.47	36.73	35.40	38.65	60.27	75.72	55.34	68.63	58.12	44.69
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.04	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.04	0.00	0.00	0.00	0.00
Financial Leverage	-0.64	-0.64	-0.66	-0.67	-0.66	-0.65	-0.68	-0.62	-0.52	-0.57
Leverage Ratio	1.48	1.48	1.50	1.51	1.55	1.61	1.62	1.72	1.82	1.83
Compound Leverage Factor	1.49	1.49	1.52	1.55	1.62	1.64	1.62	1.75	1.92	1.97
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	3.82%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	3.82%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	99.09%	99.50%	95.67%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.14	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	-2.24	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.14	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.20	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	-3.22	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.20	0.00	0.00	0.00	0.00
Altman Z-Score	8.62	9.49	9.83	12.56	12.62	15.08	16.11	14.32	12.22	10.47
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.47%	0.69%	0.52%	0.25%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.39	3.42	3.39	3.32	2.94	3.13	2.96	2.20	2.34	2.74
Quick Ratio	3.23	3.25	3.29	3.20	2.84	3.02	2.86	2.09	2.19	2.58
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	41	34	43	58	54	56	102	69	73	95
Operating Cash Flow to CapEx	1,124.54%	465.13%	1,435.72%	559.50%	469.05%	2,071.63%	1,824.90%	778.93%	778.63%	2,082.97%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.83	0.80	0.82	0.84	0.81	0.70	0.74	0.81	0.87	0.78
Accounts Receivable Turnover	3.58	3.58	3.52	3.52	3.69	3.45	3.71	3.31	3.18	3.40
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	11.03	9.67	9.70	9.36	7.75	6.59	7.78	8.18	7.62	7.53
Accounts Payable Turnover	18.91	18.73	16.95	15.92	16.34	14.32	13.62	9.86	12.49	14.91
Days Sales Outstanding (DSO)	102.06	101.94	103.64	103.83	98.84	105.74	98.41	110.21	114.74	107.43
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	19.30	19.49	21.53	22.93	22.34	25.48	26.80	37.03	29.23	24.48
Cash Conversion Cycle (CCC)	82.76	82.45	82.10	80.89	76.50	80.26	71.61	73.18	85.51	82.95
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	91	100	93	105	119	133	119	159	169	162
Invested Capital Turnover	3.45	3.30	3.62	3.83	3.72	3.17	3.69	3.68	3.27	3.37
Increase / (Decrease) in Invested Capital	1.33	8.41	-6.93	13	13	15	-14	40	9.64	-6.77
Enterprise Value (EV)	1,001	1,253	1,523	2,247	3,259	4,258	5,619	4,741	4,217	4,255
Market Capitalization	1,173	1,427	1,719	2,456	3,490	4,486	5,916	4,902	4,404	4,513
Book Value per Share	$10.21	$10.68	$11.20	$5.98	$6.72	$6.96	$8.00	$6.33	$7.03	$8.29
Tangible Book Value per Share	$9.87	$10.34	$10.87	$5.82	$6.56	$6.80	$7.84	$6.16	$6.86	$8.13
Total Capital	263	273	289	314	350	376	417	321	356	421
Total Debt	0.00	0.00	0.00	0.00	0.00	14	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	14	0.00	0.00	0.00	0.00
Net Debt	-172	-174	-196	-209	-232	-228	-298	-161	-187	-259
Capital Expenditures (CapEx)	5.38	14	4.73	16	23	4.99	6.83	12	16	6.94
Debt-free, Cash-free Net Working Capital (DFCFNWC)	21	20	26	20	8.48	7.00	2.09	29	30	25
Debt-free Net Working Capital (DFNWC)	192	194	222	228	240	250	300	190	218	284
Net Working Capital (NWC)	192	194	222	228	240	250	300	190	218	284
Net Nonoperating Expense (NNE)	-1.35	-4.95	-5.24	-1.44	-15	-12	-14	6.66	-18	-21
Net Nonoperating Obligations (NNO)	-172	-174	-196	-209	-232	-228	-298	-161	-187	-259
Total Depreciation and Amortization (D&A)	6.07	6.13	6.29	6.18	6.29	6.71	6.48	7.08	8.92	9.69
Debt-free, Cash-free Net Working Capital to Revenue	6.62%	6.38%	7.48%	5.21%	2.03%	1.75%	0.45%	5.59%	5.68%	4.44%
Debt-free Net Working Capital to Revenue	61.47%	61.51%	63.95%	60.16%	57.55%	62.40%	64.29%	37.04%	40.54%	50.80%
Net Working Capital to Revenue	61.47%	61.51%	63.95%	60.16%	57.55%	62.40%	64.29%	37.04%	40.54%	50.80%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$0.00	$1.56	$1.58	$1.92	$1.98	$1.96	$2.13
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	0.00	0.00	52.69M	52.39M	52.61M	51.73M	51.15M	51.13M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$1.53	$1.55	$1.90	$1.96	$1.94	$2.11
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	0.00	0.00	53.88M	53.32M	53.33M	52.28M	51.64M	51.57M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	0.00	0.00	51.82M	51.80M	52.12M	50.64M	50.56M	50.82M
Normalized Net Operating Profit after Tax (NOPAT)	42	43	36	71	67	71	88	109	82	88
Normalized NOPAT Margin	13.51%	13.50%	10.37%	18.66%	16.15%	17.73%	18.79%	21.23%	15.31%	15.83%
Pre Tax Income Margin	22.74%	21.94%	23.72%	24.59%	24.97%	24.24%	26.99%	25.76%	25.32%	26.39%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	35.89%	39.56%	52.86%	37.67%	40.63%	48.18%	42.68%	48.12%	53.86%	53.41%
Augmented Payout Ratio	89.36%	91.06%	81.75%	76.31%	67.26%	96.70%	49.60%	200.42%	77.99%	58.64%

This table displays calculated financial ratios and metrics derived from Exponent's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/30/2022	3/31/2023	6/30/2023	9/29/2023	12/29/2023	3/29/2024	6/28/2024	9/27/2024	1/3/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	9.26%	12.20%	9.21%	7.63%	4.84%	-3.50%	3.30%	0.22%	2.21%	11.28%
EBITDA Growth	1.59%	3.06%	3.72%	-0.60%	-0.12%	-1.84%	12.21%	8.39%	3.61%	2.27%
EBIT Growth	1.43%	2.14%	3.00%	-1.69%	-2.07%	-3.75%	11.93%	8.05%	3.79%	2.07%
NOPAT Growth	10.30%	-2.19%	-27.98%	-35.53%	-8.93%	-21.32%	-4.03%	24.08%	-23.47%	60.38%
Net Income Growth	-0.54%	10.52%	-1.64%	-0.03%	0.39%	-7.08%	3.50%	13.51%	6.14%	12.71%
EPS Growth	2.17%	15.79%	0.00%	2.04%	2.13%	-9.09%	5.36%	14.00%	4.17%	12.50%
Operating Cash Flow Growth	18.03%	-25.13%	-5.53%	34.40%	-24.54%	75.77%	255.63%	19.22%	33.84%	-21.40%
Free Cash Flow Firm Growth	16.59%	-177.39%	-135.60%	-177.57%	-225.95%	113.33%	464.73%	386.37%	315.93%	765.28%
Invested Capital Growth	6.49%	33.44%	18.04%	21.54%	26.37%	6.05%	-4.88%	-9.07%	-11.99%	-4.01%
Revenue Q/Q Growth	-2.38%	0.14%	10.17%	-0.06%	-4.91%	-7.83%	17.93%	-3.03%	-3.03%	0.36%
EBITDA Q/Q Growth	-6.77%	-9.98%	14.93%	3.05%	-6.31%	-11.53%	31.37%	-0.46%	-10.44%	-12.68%
EBIT Q/Q Growth	-6.86%	-10.91%	15.42%	2.64%	-7.22%	-12.44%	34.23%	-0.92%	-10.88%	-13.89%
NOPAT Q/Q Growth	-18.33%	-39.50%	46.74%	-11.09%	15.36%	-47.73%	78.99%	14.96%	-28.85%	9.55%
Net Income Q/Q Growth	-5.10%	-7.85%	29.30%	-11.59%	-4.70%	-14.71%	44.02%	-3.04%	-10.89%	-9.43%
EPS Q/Q Growth	-4.08%	-6.38%	27.27%	-10.71%	-4.00%	-16.67%	47.50%	-3.39%	-12.28%	-10.00%
Operating Cash Flow Q/Q Growth	-2.48%	37.89%	-116.52%	704.88%	-45.24%	221.20%	-85.37%	363.37%	-38.53%	88.64%
Free Cash Flow Firm Q/Q Growth	-19.36%	-243.91%	61.21%	-72.34%	-30.92%	115.23%	961.05%	35.32%	-1.28%	-38.95%
Invested Capital Q/Q Growth	-0.30%	-7.04%	35.73%	-3.38%	3.65%	-21.98%	21.73%	-7.63%	0.32%	-14.90%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	50.64%	41.70%	40.00%	40.92%	44.49%	35.84%	37.68%	43.46%	39.86%	42.78%
EBITDA Margin	27.18%	24.43%	25.48%	26.28%	25.89%	24.85%	27.68%	28.42%	26.25%	22.84%
Operating Margin	28.95%	17.30%	20.75%	21.31%	25.45%	14.97%	21.19%	25.43%	18.97%	19.93%
EBIT Margin	25.82%	22.97%	24.07%	24.72%	24.12%	22.91%	26.08%	26.65%	24.49%	21.02%
Profit (Net Income) Margin	19.22%	17.69%	20.76%	18.36%	18.40%	17.03%	20.80%	20.80%	19.11%	17.25%
Tax Burden Percent	73.01%	73.80%	81.95%	71.02%	72.13%	69.56%	74.57%	73.65%	72.47%	75.30%
Interest Burden Percent	101.94%	104.31%	105.24%	104.60%	105.78%	106.85%	106.95%	105.96%	107.67%	108.99%
Effective Tax Rate	26.99%	26.20%	18.05%	28.98%	27.87%	30.44%	25.43%	26.35%	27.53%	24.70%
Return on Invested Capital (ROIC)	63.53%	47.04%	44.73%	42.53%	51.23%	34.05%	40.56%	50.88%	36.78%	50.62%
ROIC Less NNEP Spread (ROIC-NNEP)	64.78%	44.31%	41.53%	39.64%	51.19%	29.38%	35.64%	49.23%	32.68%	49.24%
Return on Net Nonoperating Assets (RNNOA)	-35.08%	-27.58%	-18.76%	-17.91%	-21.70%	-15.13%	-14.65%	-23.06%	-15.26%	-28.26%
Return on Equity (ROE)	28.45%	19.46%	25.97%	24.62%	29.53%	18.92%	25.91%	27.82%	21.51%	22.36%
Cash Return on Invested Capital (CROIC)	59.48%	49.57%	33.81%	26.97%	21.03%	44.21%	43.55%	52.80%	52.33%	57.50%
Operating Return on Assets (OROA)	21.54%	18.56%	21.35%	22.59%	22.48%	19.94%	23.61%	21.98%	19.81%	16.49%
Return on Assets (ROA)	16.03%	14.29%	18.41%	16.78%	17.15%	14.82%	18.83%	17.15%	15.46%	13.53%
Return on Common Equity (ROCE)	28.37%	19.46%	25.97%	24.62%	29.53%	18.92%	25.91%	27.82%	21.51%	22.36%
Return on Equity Simple (ROE_SIMPLE)	31.33%	0.00%	29.79%	28.52%	28.82%	0.00%	27.08%	26.66%	25.92%	0.00%
Net Operating Profit after Tax (NOPAT)	27	16	24	21	24	13	23	26	19	21
NOPAT Margin	21.13%	12.77%	17.01%	15.13%	18.36%	10.41%	15.80%	18.73%	13.75%	15.00%
Net Nonoperating Expense Percent (NNEP)	-1.24%	2.73%	3.20%	2.89%	0.04%	4.67%	4.92%	1.65%	4.10%	1.38%
Return On Investment Capital (ROIC_SIMPLE)	-	5.07%	-	-	-	3.59%	-	-	-	4.87%
Cost of Revenue to Revenue	49.36%	58.30%	60.00%	59.08%	55.51%	64.16%	62.32%	56.54%	60.14%	57.22%
SG&A Expenses to Revenue	12.23%	12.80%	10.98%	12.08%	12.76%	13.52%	11.15%	12.26%	12.68%	13.34%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	21.69%	24.39%	19.25%	19.62%	19.04%	20.87%	16.49%	18.02%	20.90%	22.85%
Earnings before Interest and Taxes (EBIT)	33	29	34	35	32	28	38	37	33	29
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	35	31	36	37	35	31	40	40	36	31
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	13.73	15.28	14.55	13.12	12.16	12.37	11.15	12.26	14.00	10.72
Price to Tangible Book Value (P/TBV)	14.11	15.71	14.92	13.44	12.46	12.67	11.41	12.53	14.30	10.94
Price to Revenue (P/Rev)	8.79	9.55	9.47	8.76	7.94	8.20	7.71	8.90	10.55	8.08
Price to Earnings (P/E)	43.84	47.91	48.82	46.01	42.18	43.89	41.18	45.97	54.03	41.41
Dividend Yield	1.07%	0.99%	1.00%	1.09%	1.21%	1.20%	1.29%	1.14%	0.97%	1.26%
Earnings Yield	2.28%	2.09%	2.05%	2.17%	2.37%	2.28%	2.43%	2.18%	1.85%	2.42%
Enterprise Value to Invested Capital (EV/IC)	24.77	29.76	22.42	21.72	19.22	24.96	19.48	24.30	29.00	26.24
Enterprise Value to Revenue (EV/Rev)	8.50	9.24	9.23	8.48	7.69	7.86	7.40	8.52	10.15	7.62
Enterprise Value to EBITDA (EV/EBITDA)	31.14	34.55	35.00	32.81	30.11	30.63	28.20	31.81	37.75	28.93
Enterprise Value to EBIT (EV/EBIT)	32.77	36.43	36.97	34.76	32.06	32.75	30.16	34.05	40.40	30.97
Enterprise Value to NOPAT (EV/NOPAT)	38.84	43.50	48.21	51.33	48.43	51.30	49.27	53.46	68.59	48.11
Enterprise Value to Operating Cash Flow (EV/OCF)	39.51	50.54	51.86	43.69	43.09	33.11	27.72	30.32	34.58	29.44
Enterprise Value to Free Cash Flow (EV/FCFF)	42.94	68.63	71.80	88.35	102.07	58.12	43.60	43.84	51.87	44.69
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.54	-0.62	-0.45	-0.45	-0.42	-0.52	-0.41	-0.47	-0.47	-0.57
Leverage Ratio	1.65	1.72	1.63	1.69	1.72	1.82	1.67	1.75	1.76	1.83
Compound Leverage Factor	1.68	1.80	1.71	1.76	1.82	1.95	1.79	1.85	1.90	2.00
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	13.82	13.75	16.19	14.17	13.18	11.71	12.64	11.72	12.81	10.01
Noncontrolling Interest Sharing Ratio	0.28%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.41	2.20	2.92	2.77	2.65	2.34	3.09	2.97	3.00	2.74
Quick Ratio	2.28	2.09	2.74	2.60	2.46	2.19	2.91	2.80	2.82	2.58
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	16	-24	-9.17	-16	-21	3.15	33	45	45	27
Operating Cash Flow to CapEx	921.13%	1,382.28%	-118.26%	744.22%	671.54%	3,687.13%	703.91%	4,218.06%	1,733.61%	2,158.34%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.83	0.81	0.89	0.91	0.93	0.87	0.91	0.82	0.81	0.78
Accounts Receivable Turnover	3.22	3.31	3.28	3.17	3.11	3.18	3.22	3.17	3.11	3.40
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	8.03	8.18	8.05	7.61	7.70	7.62	7.52	7.23	7.31	7.53
Accounts Payable Turnover	9.67	9.86	9.78	13.08	12.25	12.49	12.98	15.27	15.64	14.91
Days Sales Outstanding (DSO)	113.30	110.21	111.41	115.15	117.27	114.74	113.25	115.12	117.40	107.43
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	37.75	37.03	37.30	27.91	29.79	29.23	28.13	23.90	23.34	24.48
Cash Conversion Cycle (CCC)	75.55	73.18	74.11	87.24	87.48	85.51	85.12	91.22	94.06	82.95
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	171	159	216	209	217	169	206	190	191	162
Invested Capital Turnover	3.01	3.68	2.63	2.81	2.79	3.27	2.57	2.72	2.68	3.37
Increase / (Decrease) in Invested Capital	10	40	33	37	45	9.64	-11	-19	-26	-6.77
Enterprise Value (EV)	4,244	4,741	4,847	4,537	4,163	4,217	4,005	4,616	5,526	4,255
Market Capitalization	4,392	4,902	4,973	4,685	4,300	4,404	4,174	4,820	5,745	4,513
Book Value per Share	$6.26	$6.33	$6.75	$7.02	$6.95	$7.03	$7.34	$7.76	$8.09	$8.29
Tangible Book Value per Share	$6.09	$6.16	$6.58	$6.85	$6.79	$6.86	$7.17	$7.59	$7.92	$8.13
Total Capital	320	321	342	357	354	356	374	393	410	421
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-148	-161	-126	-148	-137	-187	-169	-203	-220	-259
Capital Expenditures (CapEx)	3.19	2.94	5.67	5.45	3.31	1.93	1.48	1.15	1.71	2.60
Debt-free, Cash-free Net Working Capital (DFCFNWC)	46	29	83	72	77	30	70	56	55	25
Debt-free Net Working Capital (DFNWC)	195	190	209	220	214	218	238	260	275	284
Net Working Capital (NWC)	195	190	209	220	214	218	238	260	275	284
Net Nonoperating Expense (NNE)	2.44	-6.26	-5.26	-4.53	-0.06	-8.13	-7.24	-2.90	-7.31	-3.07
Net Nonoperating Obligations (NNO)	-148	-161	-126	-148	-137	-187	-169	-203	-220	-259
Total Depreciation and Amortization (D&A)	1.72	1.86	1.99	2.19	2.36	2.38	2.32	2.49	2.39	2.49
Debt-free, Cash-free Net Working Capital to Revenue	9.24%	5.59%	15.90%	13.44%	14.15%	5.68%	12.84%	10.38%	10.12%	4.44%
Debt-free Net Working Capital to Revenue	38.96%	37.04%	39.82%	41.13%	39.48%	40.54%	44.00%	47.90%	50.46%	50.80%
Net Working Capital to Revenue	38.96%	37.04%	39.82%	41.13%	39.48%	40.54%	44.00%	47.90%	50.46%	50.80%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.47	$0.45	$0.57	$0.50	$0.48	$0.41	$0.59	$0.57	$0.51	$0.46
Adjusted Weighted Average Basic Shares Outstanding	51.49M	51.73M	51.13M	51.26M	51.20M	51.15M	51.01M	51.11M	51.18M	51.13M
Adjusted Diluted Earnings per Share	$0.47	$0.44	$0.56	$0.50	$0.48	$0.40	$0.59	$0.57	$0.50	$0.45
Adjusted Weighted Average Diluted Shares Outstanding	52.01M	52.28M	51.68M	51.69M	51.65M	51.64M	51.42M	51.52M	51.62M	51.57M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	50.64M	50.64M	50.84M	50.85M	50.62M	50.56M	50.67M	50.73M	50.76M	50.82M
Normalized Net Operating Profit after Tax (NOPAT)	27	16	24	21	24	13	23	26	19	21
Normalized NOPAT Margin	21.13%	12.77%	17.01%	15.13%	18.36%	10.41%	15.80%	18.73%	13.75%	15.00%
Pre Tax Income Margin	26.32%	23.96%	25.33%	25.85%	25.51%	24.48%	27.89%	28.24%	26.37%	22.91%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	47.42%	48.12%	50.30%	51.15%	52.04%	53.86%	54.39%	53.51%	53.73%	53.41%
Augmented Payout Ratio	189.35%	200.42%	155.65%	94.37%	82.09%	77.99%	83.66%	82.05%	65.90%	58.64%

Frequently Asked Questions About Exponent's Financials

When does Exponent's fiscal year end?

According to the most recent income statement we have on file, Exponent's financial year ends in January. Their financial year 2025 ended on January 3, 2025.

How has Exponent's net income changed over the last 9 years?

Exponent's net income appears to be on an upward trend, with a most recent value of $109.00 million in 2024, rising from $43.60 million in 2015. The previous period was $100.34 million in 2023. View Exponent's forecast to see where analysts expect Exponent to go next.

What is Exponent's operating income?

Exponent's total operating income in 2024 was $119.56 million, based on the following breakdown:

Total Gross Profit: $228.50 million
Total Operating Expenses: $108.95 million

How has Exponent revenue changed over the last 9 years?

Over the last 9 years, Exponent's total revenue changed from $312.83 million in 2015 to $558.51 million in 2024, a change of 78.5%.

How much debt does Exponent have?

Exponent's total liabilities were at $356.20 million at the end of 2024, a 22.5% increase from 2023, and a 185.6% increase since 2015.

How much cash does Exponent have?

In the past 9 years, Exponent's cash and equivalents has ranged from $114.97 million in 2016 to $297.69 million in 2021, and is currently $258.90 million as of their latest financial filing in 2024.

How has Exponent's book value per share changed over the last 9 years?

Over the last 9 years, Exponent's book value per share changed from 10.21 in 2015 to 8.29 in 2024, a change of -18.7%.

Related Companies

This page (NASDAQ:EXPO) was last updated on 5/8/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Exponent (EXPO) Financials

Frequently Asked Questions About Exponent's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Exponent (EXPO) Financials

Annual Income Statements for Exponent

Quarterly Income Statements for Exponent

Annual Cash Flow Statements for Exponent

Quarterly Cash Flow Statements for Exponent

Annual Balance Sheets for Exponent

Quarterly Balance Sheets for Exponent

Annual Metrics and Ratios for Exponent

Quarterly Metrics and Ratios for Exponent

Frequently Asked Questions About Exponent's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools